Abstract |
Decades of research have established that the most effective treatment for sickle cell disease (SCD) is increased fetal hemoglobin (HbF). Identification of a drug specific for inducing γ- globin expression in pediatric and adult patients, with minimal off-target effects, continues to be an elusive goal. One hurdle has been an assay amenable to a high-throughput screen (HTS) of chemicals that displays a robust γ- globin off-on switch to identify potential lead compounds. Assay systems developed in our labs to understand the mechanisms underlying the γ- to β- globin gene expression switch during development has allowed us to generate a cell-based assay that was adapted for a HTS of 121,035 compounds. Using chemical inducer of dimerization (CID)-dependent bone marrow cells (BMCs) derived from human γ- globin promoter- firefly luciferase β- globin promoter- Renilla luciferase β- globin yeast artificial chromosome (γ-luc β-luc β-YAC) transgenic mice, we were able to identify 232 lead chemical compounds that induced γ- globin 2-fold or higher, with minimal or no β- globin induction, minimal cytotoxicity and that did not directly influence the luciferase enzyme. Secondary assays in CID-dependent wild-type β-YAC BMCs and human primary erythroid progenitor cells confirmed the induction profiles of seven of the 232 hits that were cherry-picked for further analysis.
|
Authors | Kenneth R Peterson, Flávia C Costa, Halyna Fedosyuk, Renee Y Neades, Allen M Chazelle, Lesya Zelenchuk, Andrea H Fonteles, Parmita Dalal, Anuradha Roy, Rathnam Chaguturu, Biaoru Li, Betty S Pace |
Journal | PloS one
(PLoS One)
Vol. 9
Issue 9
Pg. e107006
( 2014)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25225870
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD34
- beta-Globins
- gamma-Globins
- Fetal Hemoglobin
|
Topics |
- Animals
- Antigens, CD34
(metabolism)
- Bone Marrow Cells
(drug effects, metabolism)
- Chromosomes, Artificial, Yeast
- Drug Discovery
- Drug Evaluation, Preclinical
- Erythroid Precursor Cells
(drug effects, metabolism)
- Fetal Hemoglobin
(biosynthesis, genetics)
- Gene Expression Regulation
(drug effects)
- Gene Targeting
- Genes, Reporter
- Genetic Loci
- Genetic Vectors
(genetics)
- Hemoglobinopathies
(drug therapy, genetics)
- High-Throughput Screening Assays
- Humans
- Mice
- Mice, Transgenic
- beta-Globins
(biosynthesis, genetics)
- gamma-Globins
(biosynthesis, genetics)
|